Overview
Lobbying Costs
75,000€
Financial year: Apr 2015 - Mar 2016
Lobbyists (Full time equivalent)
1.5 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
6
Lobbying Costs over the years
-
Info
The European Association of Hospital Pharmacists (EAHP)
EU Transparency Register
82950919755-02 First registered on 18 Oct 2012
Goals / Remit
EAHP is an association of 35 national hospital pharmacy associations. Its mission is to represent and develop the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The goals of EAHP are to:
- develop hospital pharmacy in order to promote the best and safest use of medicines and medical devices for the benefit of patients in Europe;
- create a platform for the education and training of hospital pharmacists to a level of specialisation and maintain continuing professional development (CPD); and,
- uphold the interests and advance the position of European hospital pharmacists within the healthcare systems, the EU and national authorities.
See www.eahp.eu > about usMain EU files targeted
The main EU initiatives, policies and legislative files currently followed by EAHP include developments in:
- professional qualification recognition (e.g. the emergence of the common training framework tool, the European Professional Card, and developments associated with the Professional Qualifications Directive)
- access to medicines, including medicines shortages
- clinical trial regulation
- medical device regulation
- EU initiatives in the area of health systems
- tackling antimicrobial resistance, including the better use of antibiotics and an improved research environment for new antibiotics
- eHealth, mHealth and telemedicine
- patient safety
- the implementation of the Falsified Medicines Directive
- the European Medicines Agency, the Heads of Medicines Agencies, and European Directorate for the Quality of MedicinesAddress
Head Office
Rue Abbe Cuypers, 3
Etterbeek
Brussels 1040
BELGIUM -
People
Total lobbyists declared
2
Employment time Lobbyists 100% 1 50% 1 Lobbyists (Full time equivalent)
1.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 06 Oct 2016
Name Start date End Date Anna Maria V Mirabile 06 May 2024 05 May 2026 Stephanie KOHL 12 Aug 2023 11 Mar 2024 Mr Diogo Jose TEIXEIRA PEREIRA 13 Apr 2023 11 Mar 2024 Stephanie KOHL 21 Jun 2022 21 Jun 2023 Stephanie KOHL 11 Mar 2020 11 Mar 2021 Mr Petr HORÁK 28 Feb 2020 27 Feb 2021 Ms Hildur Kristjana ÖNNUDÓTTIR 19 Jul 2019 01 Apr 2020 Stephanie KOHL 06 Mar 2019 06 Mar 2020 Mr Petr HORÁK 26 Feb 2019 28 Feb 2020 Ms Valentina DIMULESCU 06 Nov 2018 20 Apr 2019 Mr Boris LAMBERT 20 Sep 2018 03 Oct 2018 Stephanie KOHL 03 Mar 2018 02 Mar 2019 Mr Jordi MALLARACH PARÉS 14 Dec 2017 06 Sep 2018 Stephanie KOHL 20 Mar 2017 01 Mar 2018 Mr Richard Perceval Price 10 Oct 2016 28 Apr 2017 Mr Richard Perceval-Price 03 Sep 2014 28 Aug 2015 Mr David Preece 03 Sep 2014 28 Aug 2015 Mr Roberto Frontini 08 Feb 2014 07 Aug 2014 Mr David Preece 17 May 2013 16 May 2014 Mr Richard Perceval-Price 11 Apr 2013 10 Apr 2014 Complementary Information
EAHP employs a policy and advocacy officer. The President is the lead advocate for the organisation, and is supported in this role by members of the Board of Directors.
Person in charge of EU relations
Mr Richard Price (Policy and Advocacy Officer)
Person with legal responsibility
Ms Peppard Joan (President)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Trade unions and professional associations
-
Networking
Affiliation
EAHP is a member of the European Public Health Alliance (EPHA) and its ehealth, access to medicines and AMR working groups. www.epha.org
EAHP is a member of the Federation of European & International associations established in Belgium. www.faib.org
EAHP is a member of the International Pharmaceutical Federation (FIP). www.fip.org
EAHP is a member of the European Medicines Agency's Healthcare Professional's Working Party. http://www.ema.europa.eu/
EAHP is also a signatory of the www.alltrials.net campaign for transparency of clinical trial results.Member organisations
None declared
-
Financial Data
Closed financial year
Apr 2015 - Mar 2016
Lobbying costs for closed financial year
75,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
Key projects being undertaken by the European Association of Hospital Pharmacists include:
- a project to form a common training framework for hospital pharmacy specialisation in Europe
- efforts to assist all European countries in meeting the aspirations set out in the 44 European Statements of Hospital Pharmacy, including the conduct of benchmark practice surveys
- research and awareness raising activity to elucidate the problems experienced across Europe relating to medicines shortages, and the advancement of consensus solutions
- advocacy to the pharmaceutical industry to help achieve systematic bar coding of medicines to the single unit in order to facilitate bedside scanning in hospitals to reduce medication errors
- promotion of the role of the hospital pharmacist in leading efforts to combat antimicrobial resistance, especially in respect to achieving prudent use
EAHP conduct a number of events throughout the year, including live provision of education via our international annual congress and Academy Seminar Programme.
Regular publications of the EAHP include the European Journal of Hospital Pharmacy (EJHP) and the EAHP EU Monitor (an email newsletter which can be subscribed to at www.eahp.eu).Other activities
EAHP also seeks to advance robust and transparent regulation of medical devices, and supports the achievement of greater transparency in the reporting of clinical trial results.
For more information about EAHP policy and advocacy activity visit www.eahp.eu > practice and policy
For more information about EAHP events visit www.eahp.eu > Events
For more information about EAHP publications visit www.eahp.eu > Publications- Meetings
Meetings
6 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
Other Lobbyists - European Patients' Forum (EPF)
- Medichem, S.A.
- European Healthcare Distribution Association
- Pfizer Inc.
- Fresenius Kabi Deutschland GmbH
- Bureau Européen des Unions de Consommateurs
- European Chemical Industry Council
- MEDICINES FOR EUROPE
- Leuphana Universität Lüneburg
- SANOFI
- Phamaceutical Group of the European Union
- Teva Pharmaceuticals Europe BV
- European Federation of Pharmaceutical Industries and Associations
- Novo Nordisk A/S
-
Date 30 Sep 2020 Location Online Subject Call with pharmaceutical and medical device supply Chain on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
- Stella Kyriakides (Commissioner)
Other Lobbyists - Vaccines Europe
- European Chemical Industry Council
- European Healthcare Distribution Association
- MEDICINES FOR EUROPE
- MedTech Europe
- European Confederation of Pharmaceutical Entrepreneurs
- Association of the European Self-Care Industry
- European Coordination Committee of the Radiological, Electromedical and healthcare IT Industry
- Phamaceutical Group of the European Union
- European Federation of Pharmaceutical Industries and Associations
-
Date 22 Sep 2020 Location Brussels Subject Exchange of views on the upcoming Pharmaceutical Strategy, shortages of medicines and the role of health workforce in the health systems Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
-
Date 22 Jul 2019 Location Brussels Subject Access to medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Arunas Vinciunas (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
- Alina Timofte (Cabinet member)
Other Lobbyists -
Date 01 Jul 2019 Location Brussels Subject • The current medicines shortages situation in Europe; • Our request for an investigation into the causes of shortages; and, • The general need for better information sharing about shortages. DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 03 May 2018 Location Brussels Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists - Phamaceutical Group of the European Union
- European Organisation for Research and Treatment of Cancer
- European Union of General Practitioners / Family Physicians (Union Européenne des Médecins Omnipraticiens / Médecins de Famille)
- Standing Committee of European Doctors
- European Public Health Association
- European Society of Cardiology
- European Forum for Primary Care
- European Society for Medical Oncology (ESMO)
- European Hospital and Healthcare Federation
- Meetings